Mochida Pharmaceutical Co Ltd 2024 Integrated Report
Company: Mochida Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 31
The report presents Mochida Pharmaceutical Group's FY2023 consolidated performance, including net sales of 102,885 million yen and a consolidated employee count of 1,522. It identifies five material issues and describes a Sustainability Committee supporting Group-wide sustainability activities. Environmental disclosures include FY2023 Scope 1 and Scope 2 emissions of 4,017 and 9,311 t-CO2, alongside targets to reduce carbon emissions by 46% by FY2030 and reach carbon neutrality by 2050. The report also covers human-rights policies, sustainable procurement, employee development and women's health initiatives.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.